Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
alny
/
Alnylam Pharmaceuticals Inc
ALNY
Add to Watchlist
205.420
USD
-81.200
-28.33%
Close 07-29 16:00(ET)
Quotes delayed by 15 min
205.250
USD
+205.250
After-hours (ET)
27.19B
Market Cap
50.28
P/E TTM
Alnylam Pharmaceuticals Inc
205.420
-81.200
-28.33%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Capital World Investors
12.21%
Fidelity Management & Research Company LLC
11.30%
BlackRock Institutional Trust Company, N.A.
5.27%
Capital Research Global Investors
5.08%
Vanguard Portfolio Management, LLC
4.86%
Other
61.28%
Shareholders
Shareholders
Proportion
Capital World Investors
12.21%
Fidelity Management & Research Company LLC
11.30%
BlackRock Institutional Trust Company, N.A.
5.27%
Capital Research Global Investors
5.08%
Vanguard Portfolio Management, LLC
4.86%
Other
61.28%
Shareholder Types
Shareholders
Proportion
Investment Advisor
66.80%
Investment Advisor/Hedge Fund
22.94%
Hedge Fund
3.64%
Sovereign Wealth Fund
1.83%
Research Firm
1.78%
Pension Fund
1.47%
Bank and Trust
1.46%
Private Equity
0.22%
Individual Investor
0.17%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1634
133.66M
100.11%
-6.05M
2025Q4
1441
132.38M
102.07%
-8.88K
2025Q3
1468
132.43M
102.39%
+2.53M
2025Q2
1335
129.81M
101.55%
+2.82M
2025Q1
1292
127.17M
99.72%
-2.77M
2024Q4
1248
125.34M
101.87%
-989.05K
2024Q3
1210
126.51M
99.20%
+3.13M
2024Q2
1165
122.70M
94.98%
+5.27M
2024Q1
1152
117.38M
97.56%
-6.00M
2023Q4
1149
120.10M
100.10%
-712.55K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Capital World Investors
16.30M
12.29%
-132.48K
-0.81%
Dec 31, 2025
Fidelity Management & Research Company LLC
15.08M
11.37%
-821.92K
-5.17%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.04M
5.31%
+453.92K
+6.89%
Dec 31, 2025
Capital Research Global Investors
6.78M
5.11%
-443.13K
-6.14%
Dec 31, 2025
JP Morgan Asset Management
4.00M
3.01%
+130.78K
+3.38%
Dec 31, 2025
State Street Investment Management (US)
3.23M
2.43%
+147.48K
+4.79%
Dec 31, 2025
Invesco Capital Management (QQQ Trust)
2.81M
2.12%
-68.68K
-2.39%
Feb 28, 2026
Geode Capital Management, L.L.C.
2.65M
2%
+151.48K
+6.06%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Global X Genomics & Biotechnology ETF
6.48%
ProShares Ultra Nasdaq Biotechnology
5.81%
Invesco Nasdaq Biotechnology ETF
5.77%
Franklin Genomic Advancements ETF
5.35%
iShares Biotechnology ETF
5.07%
VanEck Biotech ETF
4.56%
American Century Focused Dynamic Growth ETF
3.76%
Goldman Sachs Future Health Care Equity ETF
3.42%
First Trust NYSE Arca Biotechnology Index Fund
3.33%
Invesco NASDAQ Next Gen 100 ETF
3.28%
View more
Global X Genomics & Biotechnology ETF
Proportion
6.48%
ProShares Ultra Nasdaq Biotechnology
Proportion
5.81%
Invesco Nasdaq Biotechnology ETF
Proportion
5.77%
Franklin Genomic Advancements ETF
Proportion
5.35%
iShares Biotechnology ETF
Proportion
5.07%
VanEck Biotech ETF
Proportion
4.56%
American Century Focused Dynamic Growth ETF
Proportion
3.76%
Goldman Sachs Future Health Care Equity ETF
Proportion
3.42%
First Trust NYSE Arca Biotechnology Index Fund
Proportion
3.33%
Invesco NASDAQ Next Gen 100 ETF
Proportion
3.28%